Academic History
Guillermo Garcia-Manero, MD, is a Professor in the Department of Leukemia and the Chief in the Section of Myelodysplastic Syndromes at The University of Texas MD Anderson Cancer Center, Houston, TX.
Prof. Garcia-Manero obtained his Medical Degree from the University of Zaragoza, School of Medicine, Zaragoza, Spain. He then underwent a Clinical Internship and Residency in Internal Medicine and a Clinical Fellowship in Hematology and Medical Oncology at Thomas Jefferson University Hospital, Philadelphia, PA.
For the past 15 years, Prof. Garcia-Manero has focused on improving outcomes and quality of life for patients with leukemia and myelodysplastic syndrome (MDS). He leads the world’s largest MDS program and directs the MDS/acute myeloid leukemia (AML) Moon Shot® program at MD Anderson. His research aims to understand the pathophysiology of these disorders and develop new treatments, resulting in over 800 publications and numerous therapeutic clinical trials.
Speaking on the pathophysiology and treatment of MDS and AML
Prof. Garcia-Manero shares his insights into the pathophysiology and treatment of MDS and AML. He focuses on key clinical trials investigating novel treatment options and cytogenetic and molecular abnormalities.
